{
  "patient_id": "b574cb07-39c2-0504-6779-cddeb5309999",
  "timestamp": "2025-12-18T15:33:43.185Z",
  "original_letter": "Peter Shull, PharmD\nClearview Primary Care\nNPI: 1234567890\nPhone: 555-555-1212  Fax: 555-555-1213\n123 Main St, Anytown, ST 12345\n\n2025-12-18\n\nMedical Benefits\nAttn: Attention: Prior Authorization Department\nHealth Insurance Co.\n\nSubject: Prior Authorization Request for Wegovy (semaglutide) for Rudolph554 Hirthe744\n\nRe: Rudolph554 Hirthe744 (DOB: 1985-02-08) | Patient ID: b574cb07-39c2-0504-6779-cddeb5309999\n\nDear Medical Director,\n\nThis letter serves to request prior authorization coverage for the prescription of Wegovy (semaglutide), 2.4 mg, subcutaneous injection, weekly, for chronic weight management in Mr. Rudolph554 Hirthe744.\n\nClinical Summary:\n- BMI: 30.5 as of [no specific date provided]\n- No qualifying comorbidities identified\n- No contraindications were identified in the reviewed record\n\nMedical Necessity & Coverage Criteria:\n- Patient meets BMI criteria (\u226530.0) for obesity management without a qualifying comorbidity\n- Wegovy is prescribed at an appropriate dose and frequency for chronic weight management\n\nSafety Review:\nNo contraindications were identified in the reviewed record, including pregnancy/lactation, MTC/MEN2 (personal/family history), concurrent GLP-1/GLP-1-GIP therapy, or pancreatitis history.\n\nRequested Action:\nWe kindly request that you approve prior authorization for Wegovy as prescribed to manage Mr. Hirthe744's chronic weight condition.\n\nAttachments:\n- Most recent vitals or BMI documentation\n- Problem list reflecting qualifying comorbidity (if applicable)\n- Medication list\n\nSincerely,\n\n______________________________\nPeter Shull, PharmD\nClearview Primary Care\n",
  "modified_letter": "Peter Shull, PharmD\nClearview Primary Care\nNPI: 1234567890\nPhone: 555-555-1212  Fax: 555-555-1213\n123 Main St, Anytown, ST 12345\n\n2025-12-18\n\nMedical Benefits\nAttn: Attention: Prior Authorization Department\nHealth Insurance Co.\n\nSubject: Prior Authorization Request for Wegovy (semaglutide) for Rudolph554 Hirthe744\n\nRe: Rudolph554 Hirthe744 (DOB: 1985-02-08) | Patient ID: b574cb07-39c2-0504-6779-cddeb5309999\n\nDear Medical Director,\n\nThis letter serves to request prior authorization coverage for the prescription of Wegovy (semaglutide), 2.4 mg, subcutaneous injection, weekly, for chronic weight management in Mr. Rudolph554 Hirthe744.\n\nClinical Summary:\n- BMI: 30.5 as of [no specific date provided]\n- No qualifying comorbidities identified\n- No contraindications were identified in the reviewed record\n\nMedical Necessity & Coverage Criteria:\n- Patient meets BMI criteria (\u226530.0) for obesity management without a qualifying comorbidity\n- Wegovy is prescribed at an appropriate dose and frequency for chronic weight management\n\nSafety Review:\nNo contraindications were identified in the reviewed record, including pregnancy/lactation, MTC/MEN2 (personal/family history), concurrent GLP-1/GLP-1-GIP therapy, or pancreatitis history.\n\nRequested Action:\nWe kindly request that you approve prior authorization for Wegovy as prescribed to manage Mr. Hirthe744's chronic weight condition.\n\nAttachments:\n- Most recent vitals or BMI documentation\n- Problem list reflecting qualifying comorbidity (if applicable)\n- Medication list\n\nSincerely,\nDr. Jake\n______________________________\nPeter Shull, PharmD\nClearview Primary Care",
  "status": "APPROVED",
  "editor": "Manual Edit",
  "saved_at": "2025-12-18T10:33:43.958841"
}